Pfizer

HEPARIN SODIUM

Manufacturer:

Pfizer

Heparin Sodium HCPCS:

J1643

HCPCS Code Descriptor:

Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units

Category:

J Code

Heparin Sodium NDCs:

00069-0043-01, 00069-0059-01, 00069-0059-03, 00069-0058-01, 00069-0137-03

Primary Type:

Anti-coagulant

Generic/Specialty Status:

Single-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00069-0043-01, 00069-0059-01, 00069-0059-03, 00069-0058-01, 00069-0137-03

About Heparin Sodium:

HEPARIN SODIUM is an Anti-coagulant drug manufactured by Pfizer and administered via the Injection route of administration. The J Code: J1643 is aligned to the drug HEPARIN SODIUM.

ACCESS PRICING AND MORE BY REGISTERING

J1643 Added Date:

January 1, 2023

J1643 Effective Date:

January 1, 2023

J1643 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Heparin Sodium billing and coding information.
Our team did not identify a source for Heparin Sodium patient assistance information. Please reach out to our team if you feel that this is a mistake.
HEPARIN SODIUM prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for HEPARIN SODIUM. Please check back in a few weeks.